Dr.Reddy's Laboratories Ltd (REDY.NS)
2,099.70INR
19 Jun 2013
Rs-31.25 (-1.47%)
Rs2,130.95
Rs2,137.00
Rs2,143.00
Rs2,078.40
233,753
363,223
Rs2,207.15
Rs1,526.40
REDY.NS
About
Overall
| Beta: | 0.66 |
| Market Cap (Mil.): | Rs362,245.00 |
| Shares Outstanding (Mil.): | 169.99 |
| Dividend: | 15.00 |
| Yield (%): | 0.70 |
Financials
| REDY.NS | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 21.62 | 30.37 | 30.65 |
| EPS (TTM): | 98.58 | -- | -- |
| ROI: | 20.37 | 19.50 | 18.83 |
| ROE: | 25.71 | 20.27 | 19.74 |
Sensex gains; inflation springs downside surprise
MUMBAI - The BSE Sensex edged up on Tuesday as lenders such as State Bank of India and Axis Bank gained after the wholesale inflation index eased to its lowest in more than three years, spurring hopes the RBI would continue to cut rates.
MARKET EYE-Indian shares flat; Dr.Reddy's gains, Tata Steel falls
* India's main BSE share index gains 0.08 percent, while the broader NSE index is up 0.1 percent, in range-bound trading after the indexes slumped more than 2 percent on Monday. * Dr.Reddy's Laboratories Ltd gains 1 percent ahead of its January-March results later in the day. * Tata Steel Ltd's shares fall 2 percent after the company said it would book a $1.6 billion impairment charge for the financial year ended March 31 due to weak economic and market conditions in Europe. * Investors are als
Dr Reddy's hits all-time high ahead of Jan-March earnings
Reuters Market Eye - Shares in Dr.Reddy's Laboratories Ltd gain as much as 2.9 percent to an all-time high of 2,152 rupees on hopes the Indian drugmaker will beat earnings estimates for the March quarter by a wide margin, according to multiple dealers.
MARKET EYE-India's Dr.Reddy's hits all-time high ahead of Jan-March earnings
* Shares in Dr.Reddy's Laboratories Ltd gain as much as 2.9 percent to an all-time high of 2,152 rupees on hopes the Indian drugmaker will beat earnings estimates for the March quarter by a wide margin, according to multiple dealers. * They cite market speculations that Dr.Reddy's will report a net profit of over 5 billion rupees ($91.43 million) for the January-March period versus analyst estimates of 4.46 billion rupees as provided by Thomson Reuters StarMine. * Dr.Reddy's shares up 1.3 percen
India's NSE index hits 28-month high
MUMBAI, May 11 - India's NSE index rose marginally on Saturday to its highest level since January 2011, led by Dr. Reddy's Laboratories Ltd, and ITC Ltd ahead of their quarterly earnings releases next week. The broader NSE index rose 0.21 percent, or 12.50 points, to end at 6,107.25. The benchmark BSE index rose 0.20 percent, or 39.70 points, to end at 20,122.32. Shares in Dr. Reddy's Laboratories stock rose 3.85 percent, while ITC ended 0.28 percent higher. The market was
Dr Reddy's shares gain on Zenatane launch
Reuters Market Eye - Shares in Dr.Reddy's Laboratories gain 2.1 percent after the company on Thursday said in a statement that it launched Zenatane, a generic version of Accutane drug, following its approval by the United States Food & Drug Administration.
MARKET EYE-Dr Reddy's shares gain on Zenatane launch
* Shares in Dr.Reddy's Laboratories Ltd gain 2.1 percent after the company on Thursday said in a statement that it launched Zenatane, a generic version of Accutane drug, following its approval by the United States Food & Drug Administration. * The company added that the drug had $309 million in sales for the most recent twelve months ending January 2013, according to IMS Health. * "Assuming an incremental 20-25 percent price drop and 20 percent market share, this could be $50 million per year r
Sensex falls to four-month low; politics, Cyprus weigh
MUMBAI - The BSE Sensex fell for a sixth consecutive session on Friday to its lowest close in four months as blue chips such as State Bank of India continued to reel from concerns about political instability and doubts over the prospect of future rate cuts.
MARKET EYE-Indian shares choppy; Tata Motors up, Dr Reddy's down
* The BSE index is down 0.02 percent while the 50-share NSE index is 0.03 percent higher. * Shares remain choppy after the Dravida Munnetra Kazhagam (DMK) party pulled out of India's ruling coalition on Tuesday, raising doubts about the fate of government's reforms. * Asian shares also hovered near their lowest in nearly three months on Friday and the euro was under pressure as investors grew concerned about a possible debt default by Cyprus and deteriorating economic activity in the euro zone
MARKET EYE-Indian shares fall; Tata Motors, DLF, Dr Reddy's hit
* The BSE index is down 0.38 percent and the 50-share NSE index falls 0.45 percent. * Tata Motors shares fall 1.5 percent a day after the company said its October-December earnings fell 52 percent to $303 million. * Shares in DLF Ltd fell as much as 3.6 percent a day after India's largest listed real estate developer reported a net profit of 2.85 billion rupees, which missed market expectations. * Dr. Reddy's Laboratories , India's No.2 drugmaker by sales, reported a larger-than-expected 29.
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
